UAE's Lunate, Blue Owl Acquire Stake in Linden Capital
Lunate manages assets worth $105 billion, backed by Abu Dhabi sovereign funds.
Abu Dhabi's Lunate, an alternative investment manager, and Blue Owl Capital, a NYSE-listed asset management firm, have jointly purchased a minority stake in Linden Capital Partners, a healthcare private equity firm based in Chicago.[1]
The undisclosed transaction was facilitated through Blue Owl's GP Strategic Capital platform and Lunate's joint venture.
Linden, managing around $8 billion in regulatory assets, specializes in healthcare services, medical products, and specialty distribution, with investments spanning over 45 companies across 350 transactions.
This move follows Blue Owl's collaboration with Lunate's parent company, Chimera Investment LLC, marking their foray into private market investment managers.
Lunate manages assets worth $105 billion, backed by Abu Dhabi sovereign funds.
In April, UAE’s Lunate and Saudi Olayan Financing Company purchased a 49% stake in ICD Brookfield Place (ICDBP).
